Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Gen Dent ; 64(4): 20-3, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27367628

RESUMO

Coffee is one of the most widely consumed beverages throughout the world. Its stimulating nature is responsible for much of its popularity, which paradoxically has resulted in its reputation for negative effects on consumer health. This review will address recent research on the systemic and dental health effects of coffee. Many of its supposed harmful effects have been disproved, while many protective and beneficial roles for coffee are emerging.


Assuntos
Café , Odontologia , Café/efeitos adversos , Humanos
2.
J Am Dent Assoc ; 147(4): 278-87, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26822100

RESUMO

BACKGROUND: The authors compared the local anesthetic efficacy and safety of an intranasally administered formulation of tetracaine and oxymetazoline (K305) with placebo in adult participants undergoing single dental restorative procedures in teeth nos. 4 through 13. METHODS: The authors screened and allocated 150 participants in a double-masked, randomized fashion to either K305 or placebo nasal spray. The authors delivered the study drug as two 0.2-milliliter sprays separated by 4 minutes inside the nostril on the side ipsilateral to the tooth being treated. The authors administered a third 0.2-mL spray, if necessary, and administered 4% articaine with 1:200,000 epinephrine by means of injection if anesthesia was inadequate. Safety evaluations included participant reports of adverse events, vital signs, and alcohol sniff tests during the 2-hour study period and at a 1-day follow-up visit. The primary efficacy end point was anesthetic success defined as the completion of the dental procedure without the need for rescue injectable local anesthetic. The authors evaluated differences in success rates observed between K305 and placebo by using a 1-sided Fisher exact test. RESULTS: The overall success rates were 88.0% (95% confidence interval, 80.0-93.6) and 28% (95% confidence interval, 16.2-42.5) for K305 and placebo, respectively (P < .0001). The most frequent adverse effects in the K305 group were rhinorrhea (57.0%) and nasal congestion (26.0%). No serious adverse events occurred during this study. CONCLUSIONS: K305 was effective and well tolerated during restorative procedures in adult participants. PRACTICAL IMPLICATIONS: K305 provides a needleless alternative for obtaining maxillary pulpal anesthesia on premolars, canines, and incisors.


Assuntos
Anestesia Dentária/métodos , Anestésicos Locais/uso terapêutico , Descongestionantes Nasais/uso terapêutico , Oximetazolina/uso terapêutico , Tetracaína/uso terapêutico , Administração Intranasal , Adulto , Anestesia Dentária/efeitos adversos , Anestésicos Locais/administração & dosagem , Anestésicos Locais/efeitos adversos , Método Duplo-Cego , Combinação de Medicamentos , Feminino , Humanos , Masculino , Maxila , Descongestionantes Nasais/administração & dosagem , Descongestionantes Nasais/efeitos adversos , Oximetazolina/administração & dosagem , Oximetazolina/efeitos adversos , Tetracaína/administração & dosagem , Tetracaína/efeitos adversos , Dente/inervação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA